Safety and Efficacy of Adoptive Transfer of Stem Cell Memory Enriched Virus Specific T Cells against CMV and EBV
Year: 2025
Type: article
Language: en
Topic: CAR-T cell therapy research
Authors and affiliations:
raw_author_name: Xun‐Hong Cao
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University  Beijing 100044 China
raw_author_name: Xu‐Ying Pei
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University  Beijing 100044 China
raw_author_name: Yuan‐Yuan Zhang
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University  Beijing 100044 China
raw_author_name: Juan Xie
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University  Beijing 100044 China
raw_author_name: Jing‐Wei Tu
raw_affiliation_strings: Institute for Regenerative Medicine State Key Laboratory of Cardiology and Medical Innovation Center Shanghai East Hospital School of Life Sciences and Technology Tongji University  Shanghai 200123 China
Shanghai iCELL Biotechnology Co., Ltd Shanghai Engineering Research Center of Stem Cells Translational Medicine  Shanghai 200335 China
raw_author_name: Zhuo‐Jun Liu
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University  Beijing 100044 China
raw_author_name: Yi‐Yang Ding
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University  Beijing 100044 China
raw_author_name: Chen‐Hua Yan
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University  Beijing 100044 China
raw_author_name: Yu‐Hong Chen
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University  Beijing 100044 China
raw_author_name: Yu Wang
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University  Beijing 100044 China
raw_author_name: Lan‐Ping Xu
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University  Beijing 100044 China
raw_author_name: Xiao‐Hui Zhang
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University  Beijing 100044 China
raw_author_name: Xiao‐Jun Huang
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University  Beijing 100044 China
Peking‐Tsinghua Center for Life Sciences Academy for Advanced Interdisciplinary Studies Peking University  Beijing China
raw_author_name: Xiang‐Yu Zhao
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University  Beijing 100044 China